军事知识服务平台
多组学整合分析揭示NF1突变型胶质母细胞瘤的基因组、MES-like状态及免疫微环境特征
Integrated multi-omics analysis reveals genomic features,MES-like states,and immune microenvironment characteristics in NF1-mutant glioblastoma
摘要 背景与目的:胶质母细胞瘤(glioblastoma,GBM)是中枢神经系统肿瘤中常见且恶性程度最高的类型,具有高度异质性、治疗抵抗及微环境高度免疫抑制等特征,基于分子分型的精准诊疗以改善患者预后是当前重要的研究方向.NF1 是 RAS/MAPK 信号通路的重要负调控因子,其突变与 GBM mesenchymal/MES-like表型密切相关,但NF1突变相关的基因组特征、肿瘤细胞状态及免疫微环境改变之间的联系仍缺乏系统整合.本研究系统分析NF1突变型GBM的肿瘤细胞特征与肿瘤微环境间的分子联系,旨在为该类GBM的精准治疗及免疫微环境干预策略研究提供理论依据.方法:基于MSK队列497例GBM患者,分析比较NF1突变与总体生存期(overall survival,OS)、无进展生存期(progression-free survival,PFS)、肿瘤突变负荷(tumor mutational burden,TMB)及替莫唑胺(temozolomide,TMZ)相关高突变特征及DNA修复相关基因改变的关系.利用GEO单细胞转录组数据分析肿瘤细胞状态、髓系细胞和T细胞相关亚群,并结合基因集富集分析(gene set enrichment analysis,GSEA)、基因集评分和CellChat分析评价转录程序及潜在细胞通信.在160例TCGA-GBM bulk RNA-seq队列中验证MES-like转录特征,并进行加权基因共表达网络分析(weighted gene co-expression network analysis,WGCNA)、配体-受体评分及免疫相关评分分析.进一步采用CRISPR/Cas9技术构建NF1敲除U87-MG细胞模型(U87_sgNF1),通过蛋白质印迹法(Western blot)验证NF1蛋白表达变化,并通过实时荧光定量聚合酶链反应(real-time fluorescence quantitative polymerase chain reaction,RTFQ-PCR)验证转录水平的变化.结果:NF1突变型GBM具有更高的TMB水平,并富集TMZ相关高突变特征,校正背景突变负荷及TMZ相关高突变状态后,NF1突变仍与MMR相关基因改变显著相关.单细胞分析显示,NF1突变型GBM中MES-like肿瘤细胞状态增强,并伴随TNF-α/NF-κB、缺氧、炎症反应及KRAS等相关转录程序激活.TCGA-GBM队列进一步验证了MES-like转录特征,并显示NF1突变伴随多个涉及细胞外基质、TGF-β信号及细胞周期/基因组维持过程的共表达模块变化.RTFQ-PCR结果同样显示,U87_sgNF1细胞中MES-like状态及其他相关转录程序的代表性基因表达变化趋势,与公共单细胞数据集的基因集打分结果总体一致.免疫细胞组成分析显示,NF1 突变型 GBM 的 M2-like 和 Hypoxic 髓系细胞亚群比例升高,Inflammatory及Treg亚群比例升高.CellChat分析提示M2-like髓系细胞指向MES-like肿瘤细胞的SPP1相关潜在通信增强;同时,MES-like肿瘤细胞指向M2-like髓系细胞及T淋巴细胞的SPP1-CD44、FN1-CD44、COL1A1-CD44及COL6A1-CD44等候选通信亦增强.TCGA-GBM队列验证显示,上述通信评分与MES score及多种免疫相关评分呈显著正相关.结论:NF1突变型GBM具有较高TMB、TMZ相关高突变及特定DNA修复相关改变,并与MES-like转录状态增强、共表达网络变化及免疫微环境相关特征相伴随.其免疫微环境中MES-like肿瘤细胞与M2-like髓系细胞及T淋巴细胞之间可能存在SPP1/CD44及其他细胞外基质-CD44相关的潜在通信模式.本研究从基因组、肿瘤细胞状态及免疫微环境等多个层面补充了NF1突变型GBM的生物学特征,并为后续机制验证及潜在干预研究提供候选方向.
Abstract:
Background and purpose:Glioblastoma(GBM)is one of the most common and most malignant tumors of the central nervous system.It is characterized by marked heterogeneity,therapeutic resistance,and a highly immunosuppressive microenvironment.Precision diagnosis and treatment based on molecular classification represents an important research direction for improving patient prognosis.NF1 is an important negative regulator of the RAS/MAPK pathway,and its mutations have been closely associated with the mesenchymal/MES-like phenotype of GBM.However,the relationships among NF1 mutation-associated genomic features,tumor cell states,and alterations in the immune microenvironment remain incompletely integrated.This study aimed to characterize the tumor cell features and tumor microenvironment-associated molecular relationships of NF1-mutant GBM and to provide a basis for further investigation of precision therapeutic and immune microenvironment-targeted strategies.Methods:A total of 497 patients with GBM from the MSK cohort were analyzed to evaluate the associations of NF1 mutation with overall survival(OS),progression-free survival(PFS),tumor mutational burden(TMB),temozolomide(TMZ)-associated hypermutation,and DNA repair-related gene alterations.Single-cell transcriptomic data from the GEO dataset were used to analyze tumor cell states,myeloid cell subsets,and T cell-related subsets.Gene set enrichment analysis(GSEA),gene set scoring,and CellChat analysis were applied to evaluate transcriptional programs and potential ligand-receptor communication.MES-like transcriptional features were further validated in a TCGA-GBM bulk RNA-seq cohort of 160 patients,followed by weighted gene co-expression network analysis(WGCNA),ligand-receptor scoring,and immune-related scoring.In addition,an NF1-knockout U87-MG cell line(U87_sgNF1)was generated using CRISPR/Cas9 technology,and Western blot and real-time fluorescence quantitative polymerase chain reaction(RTFQ-PCR)were performed to validate NF1 protein depletion and selected transcriptional changes.Results:NF1-mutant GBM showed higher TMB and enrichment of TMZ-associated hypermutation.After adjustment for background mutational burden and TMZ-associated hypermutation,NF1 mutation remained significantly associated with mismatch repair(MMR)-related gene alterations.Single-cell analysis showed an enhanced MES-like tumor cell state in NF1-mutant GBM,accompanied by increased TNF-α/NF-κB,hypoxia,inflammatory response,and KRAS-related transcriptional programs.The TCGA-GBM cohort further validated the MES-like transcriptional phenotype and showed that NF1 mutation was associated with multiple co-expression modules involving extracellular matrix organization,TGF-β signaling,and cell-cycle/genome-maintenance processes.RTFQ-PCR analysis of U87_sgNF1 cells showed that representative genes associated with MES-like and other transcriptional programs exhibited expression changes broadly consistent with gene set scores from public single-cell datasets.Immune cell analysis showed increased proportions of M2-like and hypoxic myeloid subpopulations,as well as inflammatory and Treg subpopulations,in NF1-mutant GBM.CellChat analysis suggested enhanced inferred communication involving SPP1-CD44 and SPP1-integrin axes between immune cells and MES-like tumor cells.In the reverse direction,MES-like tumor cells also showed increased potential communication with M2-like myeloid cells and T cells through SPP1/CD44-,FN1/CD44-,COL1A1/CD44-and COL6A1/CD44-related axes.In the TCGA-GBM cohort,corresponding ligand-receptor scores were positively correlated with MES scores and multiple immune-related transcriptional scores.Conclusion:NF1-mutant GBM is characterized by higher TMB,TMZ-associated hypermutation,and specific DNA repair-related alterations,together with enhanced MES-like transcriptional states,co-expression network changes,and immune microenvironment-associated features.Potential communication involving SPP1/CD44 and other extracellular matrix-CD44-related axes may exist between MES-like tumor cells and M2-like myeloid cells,as well as between MES-like tumor cells and T cells.This study further delineates the biological features of NF1-mutant GBM across genomic,tumor cell state,and immune microenvironmental levels and provides candidate directions for subsequent mechanistic validation and potential therapeutic investigation.
刊 名 中国癌症杂志 ISTICPKU
年,卷(期): 2026, 36(9)
分类号: R739.41
机标分类号: R735.7 S181 X52
在线出版日期: 2026年11月2日